MR procedures: Biologic effects, safety, and patient care

Radiology

Volumn 232, Issue 3, 2004, Pages 635-652

  Shellock, Frank C ^a,b   Crues, John V ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Inst Magnetic Reson Safety   (United States)

^c Radnet Management   (United States)

Author keywords

Magnetic resonance (MR), biological effects; Magnetic resonance (MR), safety; Reviews

Indexed keywords

ALLOY; COSMETIC; IRIDIUM; METAL; NICKEL; NITINOL; PLATINUM; POLYETHYLENE TEREPHTHALATE; SILVER; STAINLESS STEEL; TITANIUM;

ACOUSTICS; ANEURYSM CLIP; ANNULOPLASTY; ARTIFICIAL HEART PACEMAKER; BRAIN DEPTH STIMULATION; BURN; DEVICE; FEMALE CONTRACEPTIVE DEVICE; FILTER; FOREIGN BODY; HEART VALVE PROSTHESIS; HEATING; HUMAN; IMPLANT; MAGNETIC FIELD; NERVE STIMULATION; NOISE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; RADIOFREQUENCY; REVIEW; SAFETY; SCREENING; SKIN TEMPERATURE; STENT; STOMACH PARESIS; TATTOO;

BIOPHYSICS; BURNS; ELECTROMAGNETIC FIELDS; EYE FOREIGN BODIES; HUMANS; MAGNETIC RESONANCE IMAGING; MUSCLES; NERVOUS SYSTEM; NOISE; POSTOPERATIVE PERIOD; PROSTHESES AND IMPLANTS; SAFETY; TATTOOING;

EID: 4143152698     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2323030830     Document Type: Review

References (195)

1. Schenck JF. Health effects and safety of static magnetic fields. In: Shellock FG, ed. Magnetic resonance procedures: health effects and safety. Boca Raton, Fla: CRC, 2001; 1-30.
2. Zaremba LA. FDA guidance for magnetic resonance system safety and patient exposures: current status and future considerations. In: Shellock FG, ed. Magnetic resonance procedures: health effects and safety. Boca Raton, Fla: CRC, 2001; 183-196.
3. U.S. Food and Drug Administration, Center for Devices and Radiological Health. MDR data files. Available at: www.fda.gov/CDRH/mdrfile.html. Accessed April 1, 2003.
4. U.S. Food and Drug Administration, Center for Devices and Radiological Health. Manufacturer and user facility device experience database (MAUDE): file formats for FOI releasable data. Available at: www .fda.gov/cdrh/maude.html. Accessed April 1, 2003.
5. Shellock FG. Reference manual for magnetic resonance safety, implants, and devices: 2004 edition. Los Angeles, Calif: Biomedical Research Publishing, 2004.
6. Shellock FG. Pocket guide to MR procedures and metallic objects: update 2001. Philadelphia, Pa: Lippincott Williams & Wilkins, 2001.
7. Shellock FG. Magnetic resonance procedure: health effects and safety. Boca Raton, Fla: CRC, 2001.
8. Schaefer DJ, Bourland JD, Nyenhuis JA. Review of patient safety in time-varying gradient fields. J Magn Reson Imaging 2000; 12:20-29.
9. Schenck JF. Safety of strong, static magnetic fields. J Magn Reson Imaging 2000; 12:2-19.
10. King KF, Schaefer DJ. Spiral scan peripheral nerve stimulation. J Magn Reson Imaging 2000; 12:164-170.
11. Shellock FG. Radiofrequency energy-induced heating during MR procedures: a review. J Magn Reson Imaging 2000; 12: 30-36.
12. McJury M, Shellock FG. Auditory noise associated with MR procedures: a review. J Magn Reson Imaging 2000; 12: 37-45.
13. Shellock FG, Kanal E. Policies, guidelines, and recommendations for MR imaging safety and patient management. J Magn Reson Imaging 1991; 1:97-101.
14. Kanal E, Shellock FG. Policies, guidelines, and recommendations for MR imaging safety and patient management: patient monitoring during MR examinations. J Magn Reson Imaging 1992; 2:247-248.
15. Shellock FG, Kanal E. Guidelines and recommendations for MR imaging safety and patient management. III. Questionnaire for screening patients before MR procedures. The SMRI Safety Committee. J Magn Reson Imaging 1994; 4:749-751.
16. International Electrotechnical Commission. Medical electrical equipment: particular requirements for the safety of magnetic resonance equipment for medical diagnosis. International Standard IEC 60601-2-33. Geneva, Switzerland: International Electrotechnical Commission, 2002.
17. Kanal E, Barkovich J, Bell C, et al. American College of Radiology white paper on MR safety. AJR Am J Roentgenol 2002; 178:1335-1347.
18. Shellock, FG. MRI safety, bioeffects, and patient management. Available at: www .MRIsafety.com.
19. Institute for Magnetic Resonance Safety, Education, and Research. IMRSER home. Available at: www.IMRSER.org.
20. Schenck JF, Dumoulin CL, Redington RW, Kressel HY, Elliott RT, McDougall IL. Human exposure to 4.0-tesla magnetic fields in a whole-body scanner. Med Phys 1992; 19:1089-1098.
21. Kangarlu A, Burgess RE, Zhu H, et al. Cognitive, cardiac, and physiological safety studies in ultra high field magnetic resonance imaging. Magn Reson Imaging 1999; 17:1407-1416.
22. Hong CZ, Shellock FG. Short-term exposure to a 1.5 tesla static magnetic field does not effect somato-sensory evoked potentials in man. Magn Reson Imaging 1990; 8:65-69.
23. Shellock FG, Schaefer DJ, Crues JV. Exposure to a 1.5-T static magnetic field does not alter body and skin temperatures in man. Magn Reson Med 1989; 11:371-375.
24. Brody A, Embury S, Mentzer W, Winkler M, Gooding C. Preservation of sickle cell blood flow pattern(s) during MR imaging: an in vivo study. AJR Am J Roentgenol 1988; 151:139-141.
25. Tenforde T, Budinger T. Biological effects and physical safety aspects of NMR imaging and in vivo spectroscopy. In: Thomas S, Dixon R, eds. NMR in medicine: instrumentation and clinical applications. Medical monograph no. 14. New York, NY: American Association of Physicists in Medicine, 1986; 493-548.
26. Vogl T, Pasulus W, Fuchs A, Krafczyk S, Lissner J. Influence of magnetic resonance imaging on evoked potentials and nerve conduction velocities in humans. Invest Radiol 1991; 26:432-437.
27. Weiss J, Herrick RC, Taber KH, Contant C, Plishker GA. Bio-effects of high magnetic fields: a study using a simple animal model. Magn Reson Imaging 1992; 10:689-694.
28. Yuh WT, Ehrhardt JC, Fisher DJ, Shields RK, Shellock FG. Phantom limb pain induced in amputee by strong magnetic fields. J Magn Reson Imaging 1992; 2:221-223.
29. Prasad N, Wright DA, Ford JJ, Thornby JI. Safety of 4-T MR imaging: study of effects on developing frog embryos. Radiology 1990; 174:251-253.
30. Prasad N, Bushong S, Thronby J, Bryan R, Hazelwood C, Harrell J. Effect of nuclear magnetic resonance on chromosomes of mouse bone marrow cells. Magn Reson Imaging 1984; 2:37-39.
31. Geard C, Osmak R, Hall E, Simon H, Maudsley A, Hilal S. Magnetic resonance and ionizing radiation: a comparative evaluation in vitro of oncogenic and genotoxic potential. Radiology 1984; 152:199-202.
32. Cooke P, Morris P. The effects of NMR exposure of living organism. II. A genetic study of human lymphocytes. Br J Radiol 1981; 54:622-625.
33. Schwartz J, Crooks L. NMR imaging produces no observable mutations or cytotoxicity in mammalian cells. AJR Am J Roentgenol 1982; 139:583-585.
34. Tyndall DA, Sulik KK. Effects of magnetic resonance imaging on eye development in the C57BL/6J mouse. Teratology 1991; 43:263-275.
35. Heinrichs WL, Fong P, Flannery M, et al. Midgestational exposure of pregnant BALB/c mice to magnetic resonance imaging. Magn Reson Imaging 1988; 6:305-313.
36. McRobbie D, Foster MA. Pulsed magnetic field exposure during pregnancy and implications for NMR foetal imaging: a study with mice. Magn Reson Imaging 1985; 3:231-234.
37. Brockway J, Bream P. Does memory loss occur after MR imaging? J Magn Reson Imaging 1992; 2:721-728.
38. Besson J, Foreman E, Eastwood L, Smith F, Ashcroft G. Cognitive evaluation following NMR imaging of the brain. J Neurol Neurosurg Psychiatry 1984; 47: 314-316.
39. Nyenhuis JA, Bourland J, Kildishev AV, Schaefer DJ. Health effects and safety of intense gradient fields. In: Shellock FG, ed. Magnetic resonance procedures: health effects and safety. Boca Raton, Fla: CRC, 2001; 31-54.
40. Bourland JD, Nyenhuis JA, Schaefer DJ. Physiologic effects of intense MRI gradient fields. Neuroimaging Clin N Am 1999; 9:363-377.
41. Cohen MS, Weisskoff R, Kantor H. Sensory stimulation by time varying magnetic fields. Magn Reson Med 1990; 14: 409-414.
42. Budinger TF, Fischer H, Hentshel D, Reinflder HE, Schmitt F. Physiological effects of fast oscillating magnetic field gradients. J Comput Assist Tomogr 1991; 15: 909-914.
43. Mansfield P, Harvey PR. Limits to neural stimulation in echo-planar imaging. Magn Reson Med 1993; 29:746-758.
44. Irnich W, Schmitt F. Magnetostimulation in MRI. Magn Reson Med 1995; 33: 619-623.
45. Ehrhardt JC, Lin CS, Magnotta VA, Fisher DJ, Yuh WT. Peripheral nerve stimulation in a whole-body echo-planar imaging system. J Magn Reson Imaging 1997; 7:405-409.
46. Abart J, Eberhardt K, Fischer H, et al. Peripheral nerve stimulation by time-varying magnetic fields. J Comput Assist Tomogr 1997; 21:532-538.
47. Ham CL, Engels JM, van de Weil GT, Machielsen A. Peripheral nerve stimulation during MRI: effects of high gradient amplitudes and switching rates. J Magn Reson Imaging 1997; 7:933-937.
48. Nyenhuis JA, Bourland JD, Schaefer DJ. Analysis from a stimulation perspective of magnetic field patterns of MR gradient coils. J Appl Phys 1997; 81:4314-4316.
49. McJury M. Acoustic noise and magnetic resonance procedures. In: Shellock FG, ed. Magnetic resonance procedures: health effects and safety. Boca Raton, Fla: CRC, 2001; 115-138.
50. Brummett RE, Talbot JM, Charuhas P. Potential hearing loss resulting from MR imaging. Radiology 1988; 169:539-540.
51. Quirk ME, Letendre AJ, Ciottone RA, Lingley JF. Anxiety in patients undergoing MR imaging. Radiology 1989; 170: 463-466.
52. Laurell GF. Combined effects of noise and cisplatin: short- and long-term follow-up. Ann Otol Rhinol Laryngol 1992; 101:969-976.
53. Philbin MK, Taber KH, Hayman LA. Preliminary report: changes in vital signs of term newborns during MR. AJNR Am J Neuroradiol 1996; 17:1033-1036.
54. Counter SA, Olofsson A, Borg E. Bjelke B, Haggstrom A, Grahn HF. Analysis of magnetic resonance imaging acoustic noise generated by a 4.7 T experimental system. Acta Otolaryngol 2000; 120: 739-743.
55. Price DL, De Wilde JP, Papadaki AM, Curran JS, Kitney RI. Investigation of acoustic noise on 15 MRI scanners from 0.2 T to 3 T. J Magn Reson Imaging 2001; 13:288-293.
56. Shellock FG, Ziarati M, Atkinson D, Chen DY. Determination of gradient magnetic field-induced acoustic noise associated with the use of echo planar and three-dimensional fast spin echo techniques. J Magn Reson Imaging 1998; 8:1154-1157.
57. Strainer JC, Ulmer JL, Yetkin FZ, Haughton VM, Daniels DL, Millen SJ. Functional MR of the primary auditory cortex: an analysis of pure tone activation and tone discrimination. AJNR Am J Neuroradiol 1997; 18:601-610.
58. Ulmer JL, Bharat BB, Leighton PM, et al. Acoustic echo planar scanner noise and pure tone hearing thresholds: the effects of sequence repetition times and acoustic noise rates. J Comput Assist Tomogr 1998; 22:480-486.
59. Bandettini PA, Jesmanowicz A, Van Kylen J, Birn RA, Hyde J. Functional MRI of brain activation induced by scanner acoustic noise. Magn Reson Med 1998; 39:410-416.
60. Goldman AM, Gossman WE, Friedlander PC. Reduction of sound levels with antinoise in MR imaging. Radiology 1989; 173:549-550.
61. Hurwitz R, Lane SR, Bell RA, Brant-Zawadzki MN. Acoustic analysis of gradient-coil noise in MR imaging. Radiology 1989; 173:545-548.
62. Counter SA, Olofsson A, Grahn, Borg E. MRI acoustic noise: sound pressure and frequency analysis. J Magn Reson Imaging 1997; 7:606-611.
63. Hedeen RA, Edelstein WA. Characteristics and prediction of gradient acoustic noise in MR imagers. Magn Reson Med 1997; 37:7-10.
64. Cho ZH, Park SH, Kim JH, et al. Analysis of acoustic noise in MRI. Magn Reson Imaging 1997; 15:815-822.
65. Miller LE, Keller AM. Regulation of occupational noise. In: Harris CM, ed. Handbook of noise control. New York, NY: McGraw-Hill, 1979; 1-16.
66. Melnick W. Hearing loss from noise exposure. In: Harris CM, ed. Handbook of noise control. New York, NY: McGraw-Hill, 1979; 2.
67. Schaefer DJ. Safety aspects of radio-frequency power deposition in magnetic resonance. Magn Reson Imaging Clin N Am 1998; 6:775-789.
68. Morvan D, Leroy-Willig A, Jehenson P, Cuenod CA, Syrota A. Temperature changes induced in human muscle by radiofrequency H-1 coupling: measurement with an MR imaging diffusion technique. Radiology 1992; 185:871-874.
69. Shellock FG, Crues JV. Temperature, heart rate, and blood pressure changes associated with clinical MR imaging at 1.5 T. Radiology 1987; 163:259-262.
70. Shellock FG, Crues JV. Temperature changes caused by clinical MR imaging of the brain at 1.5 tesla using a head coil. AJNR Am J Neuroradiol 1988; 9:287-291.
71. Shellock FG, Rothman B, Sarti D. Heating of the scrotum by high-field-strength MR imaging. AJR Am J Roentgenol 1990; 154:1229-1232.
72. Shellock FG, Schatz CJ. Increases in corneal temperature caused by MR imaging of the eye with a dedicated local coil. Radiology 1992; 185:697-699.
73. Shellock FG, Schaefer DJ, Crues JV. Alterations in body and skin temperatures caused by MR imaging: is the recommended exposure for radiofrequency radiation too conservative? Br J Radiol 1989; 62:904-909.
74. Kangarlu A, Shellock FG, Chakeres D. 8.0-tesla MR system: temperature changes associated with radiofrequency-induced heating of a head phantom. J Magn Reson Imaging 2003; 17:220-226.
75. Shellock FG, Schaefer DJ, Kanal E. Physiologic responses to MR imaging performed at an SAR level of 6.0 W/kg. Radiology 1994; 192:865-868.
76. Schaefer DJ. Health effects and safety of radiofrequency power deposition associated with magnetic resonance procedures. In: Shellock FG, ed. Magnetic resonance procedures: health effects and safety. Boca Raton, Fla: CRC, 2001; 55-74.
77. Shellock FG, Schaefer DJ. Radiofrequency energy-induced heating during magnetic resonance procedures: laboratory and clinical experiences. In: Shellock FG, ed. Magnetic resonance procedures: health effects and safety. Boca Raton, Fla: CRC, 2001; 75-96.
78. Shuman WP, Haynor DR, Guy AW, Wesby GE, Schaefer DJ, Moss AA. Superficial and deep-tissue increases in anesthetized dogs during exposure to high specific absorption rates in a 1.5-T MR imager. Radiology 1988; 167:551-554.
79. Gordon CJ. Normalizing the thermal effects of radiofrequency radiation: body mass versus total body surface area. Bioelectromagnetics 1987; 8:111-118.
80. National Council on Radiation Protection and Measurements. Biological effects and exposure criteria for radiofrequency electromagnetic fields. Report no. 86. Bethesda, Md: National Council on Radiation Protection and Measurements, 1986.
81. Rowell LB. Cardiovascular aspects of human thermoregulation. Circ Res 1983; 52:367-379.
82. Drinkwater BL, Horvath SM. Heat tolerance and aging. Med Sci Sports 1979; 11:49-55.
83. Kenney WL. Physiological correlates of heat intolerance. Sports Med 1985; 2: 279-286.
84. Barany FR. Abnormal vascular reaction in diabetes mellitus. Acta Med Scand Suppl 1955; 304:556-624.
85. Buskirk ER, Lundegren H, Magnusson L. Heat acclimation patterns in obese and lean individuals. Ann N Y Acad Sci 1965; 131:637-653.
86. Jauchem JR. Effects of drugs on thermal responses to microwaves. Gen Pharmacol 1985; 16:307-310.
87. Schaefer DJ, Barber BJ, Gordon CJ. Thermal effects of magnetic resonance imaging (abstr). In: Book of abstracts: Society of Magnetic Resonance in Medicine 1985. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1985; 925.
88. Sawyer-Glover A, Shellock FG. Pre-magnetic resonance procedure screening. In: Shellock FG, ed. Magnetic resonance procedures: health effects and safety. Boca Raton, Fla: CRC, 2001; 271-326.
89. Sawyer-Glover A, Shellock FG. Pre-MRI procedure screening: recommendations and safety considerations for biomedical implants and devices. J Magn Reson Imaging 2000; 12:92-106.
90. Kelly WM, Paglen PG, Pearson JA, San Diego AG, Soloman MA. Ferromagnetism of intraocular foreign body causes unilateral blindness after MR study. AJNR Am J Neuroradiol 1986; 7:243-245.
91. Otto PM, Otto RA, Virapongse C, et al. Screening test for detection of metallic foreign objects in the orbit before magnetic resonance imaging. Invest Radiol 1992; 27:308-311.
92. Jarvik JG, Ramsey JG. Radiographic screening for orbital foreign bodies prior to MR imaging: is it worth it? AJNR Am J Neuroradiol 2000; 21:245-246.
93. Seidenwurm DJ, McDonnell CH 3rd, Raghavan N, Breslau J. Cost utility analysis of radiographic screening for an orbital foreign body before MR imaging. AJNR Am J Neuroradiol 2000; 21:426-433.
94. Dempsey MF, Condon B, Hadley DM. Investigation of the factors responsible for burns during MRI. J Magn Reson Imaging 2001; 13:627-631.
95. A new MRI complication? Health Devices Alert, May 27, 1988; 1.
96. Thermal injuries and patient monitoring during MRI studies. Health Devices 1991; 20:362-363.
97. Jones S, Jaffe W, Alvi R. Burns associated with electrocardiographic monitoring during magnetic resonance imaging. Burns 1996; 22:420-421.
98. Keens SJ, Laurence AS. Burns caused by ECG monitoring during MRI imaging. Anaesthesia 1996; 51:1188-1189.
99. Kugel H, Bremer C, Puschel M, et al. Hazardous situation in the MR bore: induction in ECG leads causes fire. Fur Radiol 2003; 13:690-694.
100. Nakamura T, Fukuda K, Hayakawa K, et al. Mechanism of burn injury during magnetic resonance imaging (MRI): simple loops can induce heat injury. Front Med Biol Eng 2001; 11:117-129.
101. Shellock FG, Slimp G. Severe burn of the finger caused by using a pulse oximeter during MR imaging (letter). AJR Am J Roentgenol 1989; 153:1105.
102. Smith CD, Nyenhuis JA, Kildishev AV. Health effects of induced electrical currents: implications for implants. In: Shellock FG, ed. Magnetic resonance procedures: health effects and safety. Boca Raton, Fla: CRC, 2001; 393-413.
103. Shellock FG. MR safety update 2002: implants and devices. J Magn Reson Imaging 2002; 16:485-496.
104. Chou CK, McDougall JA, Can KW. Absence of radiofrequency heating from auditory implants during magnetic resonance imaging. Bioelectromagnetics 1995; 16:307-316.
105. Nyenhuis JA, Kildishev AV, Foster KS, Graber G, Athey W. Heating near implanted medical devices by the MRI RF-magnetic field. IEEE Transactions on Magnetics 1999; 35:4133-4135.
106. Rezai AR, Finelli D, Nyenhuis JA, et al. Neurostimulator for deep brain stimulation: ex vivo evaluation of MRI-related heating at 1.5-tesla. J Magn Reson Imaging 2002; 15:241-250.
107. Finelli DA, Rezai AR, Ruggieri PM, et al. MR imaging-related heating of deep brain stimulation electrodes: in vitro study. AJNR Am J Neuroradiol 2002; 23: 1795-1802.
108. Shellock FG, Hatfield M, Simon BJ, et al. Implantable spinal fusion stimulator: assessment of MRI safety. J Magn Reson Imaging 2000; 12:214-223.
109. Knopp MV, Essig M, Debus J, Zabel HJ, van Kaick G. Unusual burns of the lower extremities caused by a closed conducting loop in a patient at MR imaging. Radiology 1996; 200:572-575.
110. Becker H. The use of intradermal tattoo to enhance the final result of nipple-areola reconstruction. Plast Reconstr Surg 1986; 77:673-676.
111. Halder RM, Pham HN, Hreadon JY, Johnson HA. Micropigmentation for the treatment of vitiligo. J Dermatol Surg Oncol 1989; 15:1092-1098.
112. Carr JJ. Danger in performing MR imaging on women who have tattooed eyeliner or similar types of permanent cosmetic injections. AJR Am J Roentgenol 1995; 165:1546-1547.
113. Jackson JG, Acker H. Permanent eyeliner and MR imaging (letter). AJR Am J Roentgenol 1987; 149:1080.
114. Lund G, Wirtschafter JD, Nelson JD, Williams PA. Tattooing of eyelids: magnetic resonance imaging artifacts. Ophthalmic Surg 1986; 17:550-553.
115. Tope WD, Shellock FG. Magnetic resonance imaging and permanent cosmetics (tattoos): survey of complications and adverse events. J Magn Reson Imaging 2002; 15:180-184.
116. U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition. Office of Cosmetics and Colors fact sheet: tattoos and permanent makeup. Rockville, Md: U.S. Food and Drug Administration, 2000.
117. Vahlensieck M. Tattoo-related cutaneous inflammation (burn grade 1) in a mid-field MR scanner (letter). Eur Radiol 2000; 10:197.
118. Wagle WA, Smith M. Tattoo-induced skin burn during MR imaging (letter). AJR Am J Roentgenol 2000; 174:1795.
119. Kreidstein ML, Giguere D, Freiberg A. MRI interaction with tattoo pigments: case report, pathophysiology, and management. Plast Reconstr Surg 1997; 99: 1717-1720.
120. Kanal E, Shellock FG. MRI interaction with tattoo pigments (letter). Plast Reconstr Surg 1998; 101:1150-1151.
121. Weiss RA, Saint-Louis LA, Haik BG, McCord CD, Taveras JL. Mascara and eyelining tattoos: MRI artifacts. Ann Ophthalmol 1989; 21:129-131.
122. Colletti PM. Magnetic resonance procedures and pregnancy. In: Shellock FG, ed. Magnetic resonance procedures: health effects and safety. Boca Raton, Fla: CRC, 2001; 149-182.
123. McCarthy SM, Filly RA, Stark DD, et al. Obstetrical magnetic resonance imaging: fetal anatomy. Radiology 1985; 154: 427-432.
124. McCarthy SM, Stark DD, Filly RA, Callen PW, Hricak H, Higgins CB. Obstetrical magnetic resonance imaging: maternal anatomy. Radiology 1985; 154:421-425.
125. Tempany CM, Fielding JR. Female pelvis. In: Edelman RR, Hesselink JR, Zlatkin MB, eds. Clinical magnetic resonance imaging. 2nd ed. Philadelphia, Pa: Saunders, 1996; 1432-1466.
126. Tyndall DA. MRI effects on the teratogenicity of X-irradiation in the C57BL/6J mouse. Magn Reson Imaging 1990; 8:423-433.
127. Yip YP, Capriotti C, Yip JW. Effects of MR exposure on axonal outgrowth in the sympathetic nervous system of the chick. J Magn Reson Imaging 1995; 5:457-462.
128. Shellock FG. Biomedical implants and devices: assessment of magnetic field interactions with a 3-tesla MR system. J Magn Reson Imaging 2002; 16:721-732.
129. Shellock FG, Tkach JA, Ruggieri PM, Masaryk T, Rasmussen P. Aneurysm clips: evaluation of magnetic field interactions using "long-bore" and "short-bore" 3-tesla MR systems. AJNR Am J Neuroradiol 2003; 24:463-471.
130. Shellock FG, Tkach JA, Ruggieri PM, Masaryk TJ. Cardiac pacemakers, ICDs, and loop recorder: evaluation of translational attraction using conventional ("long-bore") and "short-bore" 1.5- and 3-tesla MR systems. J Cardiovasc Magn Reson 2003; 5:387-397.
131. Kangarlu A, Shellock FG. Aneurysm clips: evaluation of magnetic field interactions with an 8.0 T MR system. J Magn Reson Imaging 2000; 12:107-111.
132. Yuh WT, Hanigan MT, Nerad JA, et al. Extrusion of a magnetic eye implant after MR examination: a potential hazard to the enucleated eye. J Magn Reson Imaging 1991; 1:711-713.
133. Fagan LL, Shellock FG, Brenner RJ, Rothman B. Ex vivo evaluation of ferromagnetism, heating, and artifacts of breast tissue expanders exposed to a 1.5 T MR system. J Magn Reson Imaging 1995; 5:614-616.
134. Shellock FG. MR imaging and cervical fixation devices: evaluation of ferromagnetism, heating, and artifacts at 1.5 tesla. Magn Reson Imaging 1996; 14:1093-1098.
135. Shellock FG, Shellock VJ. Evaluation of cranial flap fixation clamps for compatibility with MR imaging. Radiology 1998; 207:822-825.
136. Shellock FG, Shellock VJ. Cardiovascular catheters and accessories: ex vivo testing of ferromagnetism, heating, and artifacts associated with MRI. J Magn Reson Imaging 1998; 8:1338-1342.
137. Becker RL, Norfray JF, Teitelbaum GP, et al. MR imaging in patients with intracranial aneurysm clips. AJNR Am J Neuroradiol 1988; 9:885-889.
138. Brothers MF, Fox AJ, Lee DH, Pelz DM, Deveikis JP. MR imaging after surgery for vertebrobasilar aneurysm. AJNR Am J Neuroradiol 1990; 11:149-161.
139. Brown MA, Carden JA, Coleman RE, et al. Magnetic field effects on surgical ligation clips. Magn Reson Imaging 1987; 5:443-453.
140. Burtscher IM, Owman T, Romner B, Stahlberg F, Holtas S. Aneurysm clip MR artifacts: titanium versus stainless steel and influence of imaging parameters. Acta Radiol 1998; 39:70-76.
141. Kanal E, Shellock FG. Aneurysm clips: effects of long-term and multiple exposures to a 1.5-T MR system. Radiology 1999; 210:563-565.
142. Kanal E, Shellock FG, Lewin JS. Aneurysm clip testing for ferromagnetic properties: clip variability issues. Radiology 1996; 200:576-578.
143. Klucznik RP, Carrier DA, Pyka R, Haid RW. Placement of a ferromagnetic intracerebral aneurysm clip in a magnetic field with a fatal outcome. Radiology 1993; 187:855-856.
144. New PF, Rosen BR, Brady TJ, et al. Potential hazards and artifacts of ferromagnetic and nonferromagnetic surgical and dental materials and devices in nuclear magnetic resonance imaging. Radiology 1983; 147:139-148.
145. Pride GL, Kowal J, Mendelsohn DB, Chason DP, Fleckenstein JL. Safety of MR scanning in patients with nonferromagnetic aneurysm clips. J Magn Reson Imaging 2000; 12:198-200.
146. Shellock FG, Kanal E. Yasargil clips: evaluation of interactions with a 1.5-T MR system. Radiology 1998; 207:587-591.
147. Romner B, Olsson M, Ljunggren B, et al. Magnetic resonance imaging and aneurysm clips. J Neurosurg 1989; 70:426-431.
148. Kato Y, Sano H, Katada K, et al. Effects of new titanium cerebral aneurysm clips on MRI and CT images. Minim Invasive Neurosurg 1996; 39:82-85.
149. Lawton MT, Heiserman JE, Prendergast VC, Zabramski JM, Spetzler RF. Titanium aneurysm clips. III. Clinical application in 16 patients with subarachnoid hemorrhage. Neurosurgery 1996; 38: 1170-1175.
150. Piepgras A, Guckel F, Weik T, Schmiedek P. Titanium aneurysm clips and their advantages in diagnostic imaging. Radiologe 1995; 35:830-833.
151. Wichmann W, Von Ammon K, Fink U, Weik T, Yasargil GM. Aneurysm clips made of titanium: characteristics and artifacts in MR. AJNR Am J Neuroradiol 1997; 18:939-944.
152. Shellock FG, Shellock VJ. MR-compatibility evaluation of the Spetzler titanium aneurysm clip. Radiology 1998; 206:838-841.
153. Soulen RL. Reply (letter). Radiology 1986; 158:279.
154. Soulen RL, Budinger TF, Higgins CB. Magnetic resonance imaging of prosthetic heart valves. Radiology 1985; 154: 705-707.
155. Edwards MB, Taylor KM, Shellock FG. Prosthetic heart valves: evaluation of magnetic field interactions, heating, and artifacts at 1.5-tesla. J Magn Reson Imaging 2000; 12:363-369.
156. Frank H, Buxbaum P, Huber L, et al. In vitro behavior of mechanical heart valves in 1.5 T superconducting magnet. Eur J Radiol 1992; 2:555-558.
157. Pruefer D, Kalden P, Schreiber W, et al. In vitro investigation of prosthetic heart valves in magnetic resonance imaging: evaluation of potential hazards. J Heart Valve Dis 2001; 10:410-414.
158. Shellock FG. Prosthetic heart valves and annuloplasty rings: assessment of magnetic field interactions, heating, and artifacts at 1.5 tesla. J Cardiovasc Magn Reson 2001; 3:317-324.
159. Teitelbaum GP, Bradley WG, Klein BD. MR imaging artifacts, ferromagnetism, and magnetic torque of intravascular filters, stents, and coils. Radiology 1988; 166:657-664.
160. Shellock FG, Shellock VJ. Stents: evaluation of MRI safety. AJR Am J Roentgenol 1999; 173:543-546.
161. Hennemeyer CT, Wicklow K, Feinberg DA, Derdeyn CP. In vitro evaluation of platinum Guglielmi detachable coils at 3-T with a porcine model: safety issues and artifacts. Radiology 2001; 219:732-737.
162. Hug J, Nagel E, Bornstedt A, Schackenburg B, Oswald H, Fleck E. Coronary arterial stents: safety and artifacts during MR imaging. Radiology 2000; 216:781-787.
163. Kiproff PM, Deeb DL, Contractor FM, Khoury MB. Magnetic resonance characteristics of the LGM vena cava filter: technical note. Cardiovasc Intervent Radiol 1991; 14:254-255.
164. Manke C, Nitz WR, Djavidani B, et al. MR imaging-guided stent placement in iliac arterial stenoses: a feasibility study. Radiology 2001; 219:527-534.
165. Marshall MW, Teitelbaum GP, Kim HS, et al. Ferromagnetism and magnetic resonance artifacts of platinum embolization microcoils. Cardiovasc Intervent Radiol 1991; 14:163-166.
166. Rutledge JM, Vick GW, Mullins CE, Grifka RG. Safety of magnetic resonance immediately following Palmaz stent implant: a report of three cases. Catheter Cardiovasc Interv 2001; 53:519-523.
167. Buecker A, Neuerburg JM, Adam GB, et al. Real-time MR fluoroscopy for MR-guided iliac artery stent placement. J Magn Reson Imaging 2000; 12:616-622.
168. Spuentrup E, Ruebben A, Schaeffter T, Manning WJ, Gunther RW, Buecker A. Magnetic resonance-guided coronary artery stent placement in a swine model. Circulation 2002; 105:874-879.
169. Taal BG, Muller SH, Boot H, Koop W. Potential risks and artifacts of magnetic resonance imaging of self-expandable esophageal stents. Gastrointest Endosc 1997; 46:424-429.
170. Shellock FG. New metallic implant used for permanent female contraception: evaluation of MR safety. AJR Am J Roentgenol 2002; 178:1513-1516.
171. Erlebacher JA, Cahill PT, Pannizzo F, Knowles RJ. Effect of magnetic resonance imaging on DDD pacemakers. Am J Cardiol 1986; 57:437-440.
172. Hayes DL, Holmes DR, Gray JE. Effect of 1.5 tesla nuclear magnetic resonance imaging scanner on implanted permanent pacemakers. J Am Coll Cardiol 1987; 10:782-786.
173. Holmes DRJr, Hayes DL, Gray JE, Merideth J. The effects of magnetic resonance imaging on implantable pulse generators. Pacing Clin Electrophysiol 1986; 9:360-370.
174. Zimmermann BH, Faul DD. Artifacts and hazards in NMR imaging due to metal implants and cardiac pacemakers. Diagn Imaging Clin Med 1984; 53:53-56.
175. Achenbach S, Moshage W, Diem B, Bieberle T, Schibgilla V, Bachman K. Effects of magnetic resonance imaging on cardiac pacemakers and electrodes. Am Heart J 1997; 134:467-473.
176. Peden CJ, Collins AG, Butson PC, Whitman J, Young I. Induction of microcurrents in critically ill patients in magnetic resonance systems. Crit Care Med 1993; 21:1923-1928.
177. Fontaine JM, Mohamed FB, Gottlieb C, Callans DJ, Marchlinski FE. Rapid ventricular pacing in a pacemaker patient undergoing magnetic resonance imaging. Pacing Clin Electrophysiol 1998; 21:1336-1339.
178. Fetter J, Aram G, Holmes DR, Gray JE, Hayes DL. The effects of nuclear magnetic resonance imagers on external and implantable pulse generators. Pacing Clin Electrophysiol 1984; 7:720-727.
179. Vahlhaus C, Sommer T, Lewalter T, et al. Interference with cardiac pacemakers by magnetic resonance imaging: are there irreversible changes at 0.5 tesla? Pacing Clin Electrophysiol 2001; 24(4 pt 1):489-495.
180. Gimbel JR, Johnson D, Levine PA, Wilkoff BL. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol 1996; 19:913-919.
181. Duru F, Luechinger R, Scheidegger MB, Luscher TF, Boesiger P, Candinas R. Pacing in magnetic resonance imaging environment: clinical and technical considerations on compatibility. Eur Heart J 2001; 22:113-124.
182. Pavlicek W, Geisinger M, Castle L, et al. The effects of nuclear magnetic resonance on patients with cardiac pacemakers. Radiology 1983; 147:149-153.
183. Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R. Force and torque effects of a 1.5 tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol 2001; 24:199-205.
184. Alagona P, Toole JC, Maniscalco BS, Glover MU, Abernathy GT, Prida XE. Nuclear magnetic resonance imaging in a patient with a DDD pacemaker (letter). Pacing Clin Electrophysiol 1989; 12:619.
185. Shellock FG, O'Neil M, Ivans V, et al. Cardiac pacemakers and implantable cardioverter defibrillators are unaffected by operation of extremity MR imaging system. AJR Am J Roentgenol 1999; 172: 165-170.
186. Inbar S, Larson J, Burt T, Mafee M, Ezri MD. Case report: nuclear magnetic resonance imaging in a patient with a pacemaker. Am J Med Sci 1993; 305:174-175.
187. Garcia-Bolao I, Albaladejo V, Benito A, Alegria E, Zubieta J. Magnetic resonance imaging in a patient with a dual chamber pacemaker. Acta Cardiol 1998; 53: 33-35.
188. Sommer T, Vahlhaus C, Lauck G, et al. MR imaging and cardiac pacemakers: in vitro evaluation and in vivo studies in 51 patients at 0.5 T. Radiology 2000; 215:869-879.
189. Gimbel JR. Implantable pacemaker and defibrillator safety in the MR environment: new thoughts for the new millennium. In: Kanal E, ed. Syllabus: special cross-specialty categorical course in diagnostic radiology-practical MR safety considerations for physicians, physicists, and technologists. Oak Brook, Ill: Radiological Society of North America, 2001; 69-76.
190. Gimbel JR. Interference in implanted cardiac devices (letter). Pacing Clin Electrophysiol 2003; 26(4 pt 1):922-923.
191. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-tesla. J Am Coll Cardiol 2004; 43:1315-1324.
192. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998; 339:1105-1111.
193. Rezai AR, Lozano AM, Crawley AP, et al. Thalamic stimulation and functional magnetic resonance imaging: localization of cortical and subcortical activation with implanted electrodes. J Neurosurg 1999; 90:583-590.
194. diPierro CG, Francel PC, Jackson TR, Kamiryo T, Laws ER Jr. Optimizing accuracy in magnetic resonance imaging-guided stereotaxis: a technique with validation based on the anterior commissure-posterior commissure line. J Neurosurg 1999; 90:94-100.
195. Rezai AR, Phillips M, Baker K, et al. Neurostimulation system used for deep brain stimulation (DBS): MR safety issues and implications of failing to follow guidelines. Invest Radiol 2004; 39: 300-303.